Published in Gene Therapy Weekly, April 7th, 2005
Claypool currently is chief executive officer and chairman of the board of Phoenix Data Systems, Inc. Prior to his current position, he held a number of senior level management positions in the areas of worldwide clinical development, project management, R&D portfolio management, and medical affairs at both SmithKline Beecham Pharmaceuticals and G.D. Searle, Inc.
Claypool is a graduate of the University of Notre Dame and received his medical degree from the University of Connecticut School of Medicine. He performed his medical residency and pulmonary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.